OptimizeRx Corp Files 8-K on Financials

Ticker: OPRX · Form: 8-K · Filed: Mar 12, 2025 · CIK: 1448431

Optimizerx CORP 8-K Filing Summary
FieldDetail
CompanyOptimizerx CORP (OPRX)
Form Type8-K
Filed DateMar 12, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, operations, filing

TL;DR

OptimizeRx filed an 8-K on March 12, 2025, detailing its financial condition and operations.

AI Summary

OptimizeRx Corp filed an 8-K on March 12, 2025, reporting on its financial condition and operations. The filing includes financial statements and exhibits related to the company's business activities. The company is incorporated in Nevada and its principal executive offices are located in Waltham, MA.

Why It Matters

This filing provides investors with updated financial information and operational details for OptimizeRx Corp, crucial for assessing the company's current performance and future prospects.

Risk Assessment

Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of OptimizeRx Corp, and to include Financial Statements and Exhibits.

When was this 8-K filing submitted?

This 8-K filing was submitted on March 12, 2025.

In which state is OptimizeRx Corp incorporated?

OptimizeRx Corp is incorporated in Nevada.

What is the address of OptimizeRx Corp's principal executive offices?

The address of OptimizeRx Corp's principal executive offices is 260 Charles Street, Suite 302, Waltham, MA 02453.

What is the registrant's telephone number?

The registrant's telephone number, including area code, is 248-651-6568.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 12, 2025 regarding OptimizeRx Corp (OPRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing